Literature DB >> 299815

Toxicities of adenosine and 2'-deoxyadrenosine in L cells treated with inhibitors of adenosine deaminase.

L Lapi, S S Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 299815     DOI： 10.1016/0006-2952(77)90135-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.

Authors:  T W North; S S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

Review 2.  Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

Authors:  R I Glazer
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.

Authors:  W M Shannon; G Arnett; F M Schabel; T W North; S S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

4.  Inactivation of liver S-adenosylhomocysteine hydrolase in vitro of rats treated with erythro-9-(2-hydroxynon-3-yl)adenine.

Authors:  E O Kajander
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

5.  The potential of nucleotide analogs as inhibitors of retroviruses and tumors.

Authors:  R K Robins
Journal:  Pharm Res       Date:  1984-01       Impact factor: 4.200

Review 6.  The Inside Story of Adenosine.

Authors:  Marcella Camici; Mercedes Garcia-Gil; Maria Grazia Tozzi
Journal:  Int J Mol Sci       Date:  2018-03-09       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.